Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL692515 | 0.84 | LMNA (0.30) | — | |
| SCHEMBL2574454 | 0.75 | GRIN2D (0.33) | DPP4 | |
| SCHEMBL11089627 | 0.74 | THRB (0.42) | — | |
| SCHEMBL11091802 | 0.74 | PKM (0.47) | DPP4 | |
| SCHEMBL11090307 | 0.74 | — | — | |
| SCHEMBL465574 | 0.73 | GRIN2D (0.38) | — | |
| SCHEMBL31226224 | 0.69 | DYRK3 (0.32) | DPP4 | |
| SCHEMBL6152600 | 0.69 | PKM (0.47) | — | |
| SCHEMBL7517207 | 0.67 | — | — | |
| SCHEMBL15922467 | 0.65 | PKM (0.52) | DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0028936-B1 | 4-CARBAMOYLIMIDAZOL-5-OL DERIVATIVES, THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-04-11 | — | — | EP | claimed |
| US-4332806-A | Antitumor and immunosuppresive 4-carbamoyl imidazolium-5-olate derivatives, pharmaceutical composition and production thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-06-01 | — | — | US | claimed |
| EP-0028936-A2 | 4-Carbamoylimidazol-5-ol derivatives, their production and pharmaceutical compositions containing them | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1981-05-20 | — | — | EP | claimed |